John Mattick
Vermogen: 72 863 $ op 31-08-2026
Vermogen: 72 863 $ op 31-08-2026
John Mattick is currently a Professor of RNA Biology at The University of New South Wales since 2019 and an Associate Member of the European Molecular Biology Organization.
Formerly, Dr. Mattick was Chief Executive Officer at Genomics England Ltd. from 2018 to 2019, Director at The Garvan Institute of Medical Research from 2012 to 2018, Director of the Australian Genome Research Facility at The University of Queensland, Non-Executive Director at Healius Ltd. from 2022 to 2026, and Scientific Advisor at Biobank Technology Ventures.
Education includes a doctorate from Monash University conferred in 1977 and an undergraduate degree from The University of Sydney conferred in 1971.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
HEALIUS LIMITED 0,03% | 31-03-2026 | 239.224 ( 0,03% ) | 72 863 $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
The University of New South Wales
The University of New South Wales Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01-10-2019 |
European Molecular Biology Organization | Corporate Officer/Principal | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| HEALIUS LIMITED | Directeur/Bestuurslid | 31-03-2026 |
Genomics England Ltd.
Genomics England Ltd. Miscellaneous Commercial ServicesCommercial Services Operates genomes project in research and health care for patients with cancer and rare diseases and their families | Algemeen Directeur | 01-01-2019 |
The Garvan Institute of Medical Research
The Garvan Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services Provides biomedical research | Directeur/Bestuurslid | 01-01-2018 |
The University of Queensland
The University of Queensland Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Biobank Technology Ventures
Biobank Technology Ventures Investment ManagersFinance Biobank Technology invests in companies across the globe. The firm targets the companies operating in the fields of the life sciences sectors. It provide financing for seed and early-stage transactions. | Consultant / Adviseur | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 9 |
|---|---|
Healius Ltd.
Healius Ltd. Medical/Nursing ServicesHealth Services Provides healthcare technology solutions | Health Services |
Monash University
Monash University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of New South Wales
The University of New South Wales Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Queensland
The University of Queensland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Sydney
The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biobank Technology Ventures
Biobank Technology Ventures Investment ManagersFinance Biobank Technology invests in companies across the globe. The firm targets the companies operating in the fields of the life sciences sectors. It provide financing for seed and early-stage transactions. | Finance |
European Molecular Biology Organization | |
The Garvan Institute of Medical Research
The Garvan Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services Provides biomedical research | Commercial Services |
Genomics England Ltd.
Genomics England Ltd. Miscellaneous Commercial ServicesCommercial Services Operates genomes project in research and health care for patients with cancer and rare diseases and their families | Commercial Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau